Fibroblast growth factor-4 (FGF-4) (k-FGF), a highly mitogenic protein encoded by the k-fgf/hst oncogene, stimulates the growth of a variety of cells of mesenchymal and neuroectodermal origin. Addition of FGF-4 t o human long-term bone marrow cultures increased both the cell density of the stromal layer and the number of hematopoietic colony forming cells in the cultures in a dose-dependent manner. Hematopoiesis in the stromal layer persisted for up t o 8 months. Erythropoiesis was maintained for up t o 4 weeks, but granulocytes were the predominant nonadherent cell type. Cultures treated with FGF had increased numbers of monocytes compared with control cultures and some CD14+, CD45' monocytes could still be detected after 8 months of continuous culture. The addition of the growth factor increased the rate of growth of the stromal layer and appeared t o delay TROMAL CELLS have been shown to be necessary for the survival, proliferation, and differentiation of hematopoietic cells. These effects may be a consequence of direct interactions of stromal cells with the hematopoietic progenitor or stem cells, or effects of growth factors and hormones elaborated by the stroma.' The requirement for stromal cells in hematopoiesis is readily demonstrated in long-term bone marrow cultures (LTBMC) of hematopoietic These culture systems are complex; cells of several lineages and different degrees of maturity interact to produce an environment that supports hematopoiesis for several months. Cell to cell interactions are prominent and proteoglycans capable of adsorbing growth factors and then "presenting" them to stem cells are ab~ndant."~ Stromal cell cultures derived from LTBMC have been used to develop limiting-dilution assays of LTBMC initiating cells (LTBMC-IC).S,103" The assays using human cells are less robust than the murine assays."
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In general, human LTBMC tend to be relatively shortlived and produce few multipotential cells but basic fibroblast growth factor (bFGF, FGF-2) has been reported to improve the performance of human long-term hematopoietic culture^.^^"^ The fibroblast growth factors (FGFs) are a complex family of mostly mitogenic proteins that share varying degrees of amino acid homology and bind to receptors that contain overlapping recognition sites." We now report that
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in uccordunce with 18 U.S.C. section I734 solely to indicate this fact.
0 1996 by The American Society of Hematology.
0006-497//96/8704-0018$3.00/0
its senescence. Subcultures made in the presence of FGF-4 had up t o IO-fold increases in plating efficiency and grew as relatively uniform monolayers. These subcultures retained the capacity t o support hematopoiesis for several months, while untreated subcultures, made without FGF-4, grew erratically and generally lost the capacity t o support hematopoiesis within 4 t o 6 weeks. The improved growth after subculture greatly enhanced the reliability of limit-dilution assays of multipotential hematopoietic stem cells that use stromal cell monolayers. The primary effect of FGF-4 appeared t o be on the stromal cells of the long-term bone marrow cultures, but a direct effect on hematopoietic progenitors could not be ruled out. 0 1996 b y The American Society of Hematology.
another member of the fibroblast growth factor family (FGF-4) increases the growth rate of the stromal cells and extends the hematopoietic life of the cultures. Because this form of FGF has a high-affinity for the receptor recently isolated from hematopoietic it is likely to be biologically significant. The secreted form of K-FGF (FGF-4) is a 176-amino acid, heparin binding protein encoded by the K$&/ hst o n c~g e n e . '~~~~ It was first cloned from human carcinoma and Kaposi's sarcoma cells, but is expressed in normal cells. FGF-4 is not found in normal adult tissues, but it is expressed early in development, where it plays a critical role in limb It is also expressed by embryonal carcinoma and other neoplastic cells.14~19~20*2s It is 40% homologous to human FGF-2. Unlike FGF-2, FGF-4 is an effectively secreted protein. Using FGF-4-supported stromal cultures in the LTBMC-IC assay significantly improves their reproducibility.
MATERIALS AND METHODS

Bone marrow cells.
Human bone marrow cells were obtained from discarded orthopedic specimens obtained after hip replacement. A total of 16 (1 1 men, 5 women) specimens were obtained. Donor ages ranged between 47 and 68 years. Specimens were obtained under an Institutional Review Board (IRB) approved protocol. Medullary bone was scraped into a sterile saline-filled pestle, ground, passed through a SO-pm-pore sieve and washed twice in Iscove's modified Dulbecco's medium (IMDM) containing 2% fetal bovine serum (FBS). Erythrocytes were depleted by sedimentation in methylcellulose.26 In some experiments scatter-gated progenitors were sorted and used to initiate hematopoiesis on secondary cultures of human stromal cells. When required, low-density BMC were prepared by flotation on a layer of isotonic ticoll-hypaque (specific gravity 1.083).
LTBMC. LTBMC were performed as described by Sutherland and Eaves.s The unsedimented portion was washed twice and resuspended to 1 x lo7 in LTBMC medium (containing IMDM supplemented with 10% FBS; 10% horse serum; lo-' m o m hydrocortisone; m o m a-mono thioglycerol; 50 IU/mL penicillin and SO pg/mL of streptomycin: 5 pglmL each of insulin and transferrin; S qg/mL selenious acid supplement; 2 mmom L-glutamine). FGF-4 was added at varying concentrations to experimental groups. In some experiments, the effects of equimolar concentrations (3.0 vg/mL) of FGF-4 were compared. Cultures were initiated by transfemng 8 mL of the cell suspension to 25 cm2 flasks (Falcon, Becton Dickinson Labware, Franklyn Lakes, NJ) and equilibrated with 5% COz. The LTBMC were maintained at 37°C. They were fed once weekly through week 4 and twice weekly thereafter, and weekly nonadherent cell counts were obtained from each flask. At biweekly intervals, representative cultures were used to quantify the number of cells and hematopietic progenitors present in the cultures. Adherent and nonadherent cells were assayed separately. The nonadherent cells were removed by decantation. The residual cells were washed twice with phosphate buffered saline (PBS), and the cells in the wash buffer were pooled with those removed in the first decantation. Cytocentrifuge preparations of these cells were stained with WrightGiemsa stain for differential counts, and cells from this fraction were plated in semisolid medium to determine the presence of hematopoietic progenitors. The nonadherent cells were also analyzed for immunophenotype by washing the cells and staining with monoclonal antibodies that identify hematopoietic cells, monocytes, granulocytes, T cells, and B cells.
Adherent cells were removed by washing twice with PBS-EDTA (0.02% EDTA) and incubating with 10 mL PBS-EDTA containing 0.25% trypsin. After counting, both adherent and nonadherent cells were pelleted, washed, and resuspended in IMDM. Aliquots were assayed for the presence of hematopoietic progenitors by culturing the cells in semisolid growth media. Some flasks were saved and maintained for longer periods. These flasks were fed once weekly with medium containing 3.0 ng/mL FGF-4. After 8 months, the adherent layer was examined after staining with Giemsa and for nonspecific esterase. In some experiments subcultures were prepared from the cultured stromal layers. Maximum viability and plating efficiency was attained when the subcultures were made 18 hours after feeding with fresh medium containing FGF-4. The adherent cells were dislodged by washing the plates with EDTA-saline and then trypsinizing them briefly with 0.25% trypsin in EDTA saline. Suspension of the cells was achieved by gently scraping the plates and then pipetting the cells in serum containing medium. In general the secondary cultures were -1:4 dilutions from the original cultures, but dilutions as high as 1:lO grew well.
Limiting-dilution assay of hematopoietic progenitors. Human hematopoietic precursors were estimated by a limiting dilution assay in which various numbers of separated bone marrow cells (10s to 10') were added to the wells of microtiter plates that contained preformed stromal layer^.^,'" These monolayers were prepared from 4-week-old primary cultures, which were trypsinized and distributed into the wells at a concentration of 5,000 cells/well in 0.15 W w e l l . Stromal cultures grown in the presence of FGF-4 were fed with fresh medium containing the FGF 18 hours before being trypsinized. The control cultures were fed with fresh media without FGF. Putative progenitors in LTBMC medium (50 pL) were added 3 weeks later. The progenitors were added using an automated cell deposition accessory of the Epics Elite cell sorter (Coulter, Hialeah, FL). Thirtytwo wells were assayed at each cell concentration. After 4 weeks, the wells were assayed by transfemng the entire contents of each well to a methylcellulose culture containing interleukin (L)-3, granulocyte-macrophage colony-stimulating factor (GM-CSF) stem cell factor (SCF), IL-6, and G-CSF and erythropoietin (see below) and scored 10 days later for the presence of colonies andor clusters. Wells without clonable progenitors were counted, and the frequency of progenitors in the original sample was calculated using Poisson statistics."' No hematopoietic progenitors were found in wells that received only stroma. If these cultures are to be useful as an assay of progenitors, the plot of the natural log of the fraction of wells without detectable precursors versus the number of cells added will be a straight line through the origin. The stromal cultures used in these experiments were not irradiated. LTBMC-IC can survive after primary transfer, and there is a possibility that this could distort the regression analysis. However, under the conditions described here, the number of LTBMC-IC surviving in the stroma after the first transfer is low (0.5 to 1 per 100,000 cells) and reaches an undetectable level after the second transfer.
Assay of hematopoietic progenitors (CFU-c assay).
Colonyforming cells were assayed in IMDM, supplemented with 30% FBS, 1% bovine serum albumin (BSA), and m o m 2 mercaptoethanol in the presence of appropriate growth factors. The medium was made semisolid by the addition of methylcellulose, 100,000 to 200,000 cells were cultured in four replicate cultures containing 1.0 mL of complete medium in 35 mm tissue culture dishes (Corning, Coming, NY). In the original experiments, supematants from mitogen-stimulated peripheral blood leukocytes (human) and erythropoietin (3.0 U/mL) were used to provide the growth factors necessary for multipotential cell proliferation (Methocult H4433, Stem Cell Technologies, Vancouver, BC). In subsequent experiments, the leukocyteconditioned medium was replaced with recombinant growth factors (rh Stem Cell Factor, 50 ng/mL; rh GM-CSF, 20 ng/mL; rh IL-3, 20 ng/mL; rh IL-6,20 ng/&, rh G-CSF, 20 ng/mL; Methocult GF + H4435, Stem Cell Technologies). In parallel experiments, this medium gives 50% more colonies than those supported by leukocyteconditioned medium. Under both of these conditions burst-forming unit-erythroid (BFU-e), colony-forming unit-granulocyte (CFU-G), CFU-granulocyte-macrophage (GM), and CFU-granulocyte, erythroid, monocyte, megakaryocyte (GEMM) can all be scored in the same dishes. The cultures were scored after 7 to 9 days of incubation and again at 2 weeks. Four replicates were made for each sample and a mean (2SD) calculated.
Immunojuorescence. Both the nonadherent cells in the cultures and the adherent cells released after trypsinization were stained with anti-CD45 coupled to Tricolor (clone J. Appropriate isotype controls (mouse nonimmune IgG2a and IgGl coupled to either PE or FITC) were used to determine antigen positive cells. In each preparation the cell count was adjusted to lo7/ mL with PBS. A 50-uL aliquot was incubated with a saturating concentration of antibody for 30 minutes on ice, washed once with PBS, and fixed in 4% paraformaldehyde for analysis or diluted in sterile PBS for sorting.
Flow cytometry and cell sorting. Samples were analyzed with a Becton Dickinson (San Jose, CA) FACScan cytometer equipped with a 15-mW argon laser emitting at 488 nm. Fluorescence data were collected using logarithmic amplification on 10,000 cells (both dead and viable), excluding cell debris by a combination of forward light scatter (FSC) and 90" scatter (SSC). FITC emission was measured by filtering the light passed by the dichroic mirror through a narrow-band green filter (530 nm). Phycoerythryn (PE) and Tricolor (TC) were detected by sequential dichroic mirrors, reflecting light of wavelengths longer then 560 nm first and then light of wavelengths longer than 640 nm. In each case the samples were gated on CD45 positive cells and analyzed for the lineage-defining markers.
Sorting performed on Epics Elite Cell Sorter (Coulter) equipped with an argon (488 nm) laser operating at flow rates of 700 to 2,000 celllsecond. A single cell deposition device was used to deposit the required number of cells in the wells of microtiter plates that contained stromal cell monolayers. 
RESULTS
Stromal cells.
The addition of FGF-4 to human LTBMC produced striking alterations in the cultures. The adherent, stromal cell layer showed dose-dependent increases in cell density that was apparent after 2 weeks of culture (Fig l) . with 30 ng/mL showed the greatest response (Figs 1 and 2 ). FGF-2, used at its optimal concentration (3.0 ng/mLI4), also increased adherent cell counts (Fig 2) . As shown in Fig 2, the final densities achieved in FGF-treated cultures were higher than those in the controls.
The stromal cells obtained from human LTBMC without FGF are difficult to subculture and subcultures made after 6 to 8 weeks are only sporadically able to support hematopoiesis after the addition of limited numbers of fresh bone marrow cells. In contrast, stromal cells grown in the presence of FGF-4 were readily subcultured and continued to support hematopoiesis after up to two subcultures. The effect of FGF-4 in terms of plating efficiency of subcultured stromal cells is shown in Table 1 . The capacity of the passage cells to support hematopoiesis is described below in the section on LTBMC-IC.
Hematopoietic progenitors. FGF-4 induced significant changes in the growth of hematopoietic progenitors in the LTBMC. In the cultures, hematopoietic progenitors are found both associated with the adherent stromal layer and among the nonadherent cells. The two compartments were analyzed separately. Both actual colony counts from two representative experiments and normalized data in terms of change from the controls (mean of five experiments) are shown. Normalization was used to calculate means because of the wide variability in CFU-c content in the original samples.
Adherent progenitors. The effects of adding FGF to human LTBMC on the hematopoietic progenitors recovered from the adherent layer are shown in Fig 3A and B and thereafter. The decline was much more rapid in the control cultures, without FGF, and the differences between the FGFtreated cultures and the controls became more pronounced with time. Both the increase in colony forming cells compared with the control and the length of time that CFU were preserved in the cultures were dose-dependent with a maximum effect at concentrations of FGF-4 between IO and 30 ng/mL.
Almost all of the hematopoietic CFU were myeloid-restricted progenitors. BFU-e were recovered from most cultures during the first 2 weeks, but were not found in later samples. No differences were apparent between FGF and control cultures with respect to the erythroid colonies. CFU-GEMM were not seen after 4 weeks in these experiments. Mixed monocyte-granulocyte colonies were found in all cultures for at least 6 weeks. Readily identifiable mixed colonies made up 10% to 30% of the total in most assays. The proportion appeared highly variable and did not correlate with FGF concentration (data not shown).
Virtually no colonies could be recovered from the control cultures after 8 weeks of culture, but progenitors were consistently found in FGF-supported cultures for several months. The colonies that were found in the older cultures were all single lineage CFU-M. Adherent progenitors eventually disappeared from the cultures, and by 5 months, none could be found. In general FGF-2 (3.0 ng/mL) was less effective than equimolar concentrations of FGF-4 in maintaining hematopoietic progenitors, but the differences were small and not apparent in all experiments.
Nonndherent progenitors. Although, in general, the number of nonadherent cells recovered from the cultures decreased steadily, a transient increase was noted during the fifth week after feeding intervals were decreased (Fig 5) . Neither the addition of FGF at concentration between 0.3 and 30.0 ng/mL FGF-4 nor 3.0 qg/mL FGF-2 had dramatic effects on the total number of nonadherent cells recovered, but small, statistically significant, dose-dependent changes changes with FGF-2 were only significant at week 2 ( Fig  6A and B and Fig 7) . The largest increases in colony production were obtained with 30 ng/mL FGF-4.
Although the changes in progenitor levels were more striking in the adherent cell layers, most of the CFU-c were in the nonadherent compartment. The nonadherent compartment had 4 to 5 times the number of progenitors during the first 8 weeks of culture and even after prolonged culture in the presence of FGF-4, CFU could still be detected associated with the nonadherent fraction. CFU were present in each flask, and when the cultures were terminated at 8 months, 25 to 30 CFU were still present. The distribution of hematopoietic colonies in the nonadherent compartment was indistinguishable from that found in the adherent compartment during the first 8 weeks. All of the colonies found at 5 months and at 8 months appeared to be unilineage colonies (CFU-M). Early in the cultures the majority of the nonadherent cells in the cultures were neutrophilic granulocytes at various stages of maturity. As has been reported with FGF-2-treated cultures, the proportion of granulocytes in FGF-4-treated cultures declined progressivelyI4 while the proportion of monocytes increased. Despite this, in FGF-4-treated cultures, myeloid lineage cells of all stages of maturation were present as late as 8 weeks. Promyelocytes, metamyelocytes, and bands were still present (Fig SA) . Cultures that had been treated with FGF-2 contained many relatively mature granulocytes, but had fewer immature cells (Fig 8B) . In contrast, control cultures (without any FGF) at this time consisted almost predominantly of macrophages and monocytes (Fig 8C) .
Immunophenotyping of nonadherent cells. The phenotype of the nonadherent cells cultured in the presence of FGF-4 for 3 and 6 weeks is shown in Table 2 . Virtually all of the cells expressed myeloid lineage markers. T lymphocytes (CD3') were not found in any of the cultures and B cells (CD19' cells) were found for only a brief period early in the cultures. After 8 months, the only surviving hematopoietic cells were large CD14' cells.
Stromal cell morphology. The morphology of the cells present in the adherent layer 4 weeks after the initiation of the culture is shown in Fig 9A. In addition to fibroblasts, a large number of macrophages and dendritic-type cells were present. Hematopoiesis is well established at this time. Occasionally isolated regions containing clusters of benzidine positive cells were seen in the FGF-treated cultures. Benzidine positive cells were not found in cultures made in the absence of FGF. After 8 months, the cultures appear to be senescent (Fig 9B) , but small foci of nonspecific esterasepositive monocytes were dispersed throughout the cultures.
LTBMC initiating cell assap. Stromal cell cultures derived from LTBMC have been used to develop limiting-II, *. . dilution assays of LTBMC initiating cells.'"." In these assays, stromal cultures are used to support the growth of putative progenitors. We and others" have had difficulty in obtaining reproducible results using this assay with human cells. In our experience, much of the variability is a consequence of our inability to obtain uniform stromal layers in each of the wells of the microtiter plate. The results obtained using either FGF-4-treated or control monolayers to support the cultures are shown in Fig IO. Included in the figure are the results obtained when the monolayers were prepared from secondary subcultures. These were prepared 4 weeks after the initial transfers. Control cultures, ie, cultures using stroma from secondary cultures prepared in the absence of FGF, could not be assessed as no monolayer developed in the microtiter wells. Although the incidence of LTC-IC in low-density bone marrow cultured on all of the stromal lay-QUITO ET AL ers was similar (1/4.000 to 1/5.000). the reliability of the assay, as measured by the correlation coefficients of the regression lines, is much greater in the presence of FGF-4 (>O.9 v 0.45). Secondary cultures were as effective as primary cultures in supporting the growth of multipotential progenitors. Examination of the microtiter plates. stained with crystal violet before the putative hematopoietic cells had been added, showed that the FGF-4-treated cells formed far more uniform monolayers than did the control cells.
DISCUSSION
The results presented here demonstrate that FGF-4 alters the hematopoietic potential of human LTBMC. Both the number of progenitors produced at any time and the life expectancy of the cultures are significantly increased by low concentrations of this growth factor. Similar results have been reported by Wilson et all" using FGF-2. The mechanism(s) through which FGF stimulates hematopoiesis in culture have not been established. The most obvious effect of FGF is on the cells of the adherent stromal layer. In the presence of FGF, these cells grow more rapidly, plate more efficiently after transfer, retain the capacity to support hematopoiesis for prolonged times, and, in general, appear to escape the rapid senescence characteristic of untreated human hematopoietic stromal cell cultures. A direct effect on the hematopoietic progenitors probably also contributes to these results. Two members of the family of FGF receptors (FGFR-3 and FGFR-4) were cloned from cDNA libraries that had been prepared from hematopoietic cells demonstrating the presence of these receptors in the lineage and suggesting that hematopoietic cells could be FGF-re~ponsive.~." This has been shown using FGF-2, which improves the growth and/or survival of human hematopoietic progeniAlthough human LTBMCs as originally performed by Gartner and Kaplan3 and modified subsequentlyz6 have been reported to remain viable up to 4 months, most human LTBMC senesce sooner. Wilson et all4 reported a life span for progenitor cells cultured from BM buffy coat layer cells to be 5 and 8 weeks for the nonadherent and adherent cell layers, respectively. Our cultures survive longer than this and at weeks 6 and 8 our control cultures still contained as many as 5,000 CFU per flask. The use of whole bone marrow, rather than low-density cells may result in more essential stromal cells and/or clonogenic cells seeded in LTBMC. Erythrocyte depletion may also alter the longevity of these cultures. Despite these differences, both Wilson's work and ours show that FGF-treated cultures survive much longer than conventional LTBMC. Progenitor cells (CFU-c), as well as mature myeloid cells, routinely persist for 5 months and some still remain after 8 months. The incidence of colony forming progenitors in the nonadherent layer declined by approximately 50% at each 2-week sampling. This apparent decline in nonadherent progenitors is actually indicative of a significant expansion in this compartment, as each weekly feeding of the cultures removed half of the nonadherent cells. We assume that the replication of progenitors in the adherent layer contributes to the nonadherent progenitor cell pool as has been shown previously3o but expansion of the nonadherent cells may also be occumng. Increases in colony numbers tors,15.28,29 In ' clonogenic assays.
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in the nonadherent compartment of cultures treated with FGF-4 were most pronounced at week 2 and persisted through the sixth week. Examination of cytocentrifuge preparations occasionally showed sloughing of stromal cells that could have contributed to the nonadherent cell counts.
The effect of FGF on the hematopoietic progenitors associated with the adherent layer appeared larger than the effect on the nonadherent progenitors. Adherent CFU-c increase rapidly in the early phases of the culture and the increase in hematopoietic progenitors parallels the increase in stromal cells. FGF appears to stimulate both. As the cultures age, the stromal cells increase slowly, but the hematopoietic progenitors begin to decline. The rate of this decline appears to be inversely correlated with the concentration of FGF present in the medium. In part, the apparent difference between adherent and nonadherent progenitors reflects a difference in the way the compartments are sampled. To assay progenitors in the adherent layer, the cultures are terminated and the entire layer is trypsinized to produce a single cell suspension. No depletion of adherent cells occurs as a consequence of feeding. The only losses of progenitors from the adherent layer occur as a result of migration into the culture medium. In contrast, the nonadherent cells are sampled by demi-depleting the nonadherent cells at the time of feeding.
The effects of FGF-4 differ somewhat from those of FGF-2. While FGF-2 appears to be somewhat more potent as a mitogen for the adherent cells (Fig 2) , FGF-4 had a greater effect on hematopoietic progenitor production and/or preservation ( Figs 3A and 4) . Cytocentrifuge preparations examined at 6 to 8 weeks of culture showed that stromal cells exposed to FGF-4 had more immature myeloid cells (myeloblasts, metamyelocytes, etc), while those exposed to FGF-2 had more mature cells, mainly granulocytes. The most striking difference between these closely related growth factors was the apparent absence of inhibition of hematopoiesis at high doses of FGF-4. The stimulatory hematopoietic effects of FGF-2 in LTBMC were restricted to a narrow concentration range (0.2 to 3 ng/mL). Above this, profound inhibition was reported. We have seen no such inhibition. A plateau was reached above 30 ng/mL. of FGF-4, but even 100 qg/ mL was stimulatory ( Figs 3B and 5B). In contrast, concentrations of FGF-2 as high as 100 ng/mL were stimulatory for clonal hematopoietic c~l t u r e s .~~.~~ Because FGF-4 and FGF are similar in molecular weight (176 AA v 154 AA), these concentrations reflect molar concentrations. Differences in receptor expression may account for the differences in biological response. The predominant receptors expressed by mesenchymal and neuroectodermal cells are FGFRl and 2. FGF-2 and FGF-4 have equivalent affinities for FGFR-2, and FGF-2 has a 15-fold higher affinity than FGF-4 for FGFR-1. These differences may account for the greater effect of FGF-2 on stromal proliferation. However, FGF-4 has a greater affinity for the FGFR-3 receptor isolated from hematopoietic cells16-18 and this, in turn, is likely to be responsible for a direct effect on hematopoietic progenitors.
Stromal cells have been shown to play a significant role in supporting hematopoiesis in culture and are believed to contribute to the hematopoietic microenvironment of the For personal use only. on November 11, 2017. by guest www.bloodjournal.org From marrow. The stromal cells produce both hematopoietic growth factors, including GM-CSF, IL-6, IL-1 -beta, tumor necrosis factor (TNF)-alpha3',3z and factors that regulate responses to growth factors.".33.'4 Immunohistochemical studies have shown that fibroblasts in the bone marrow stroma are labeled by GM-CSF monoclonal antibodies, suggesting the role of these cells in establishing the hematopoietic microenvironment.3' They also produce a complex proteoglycan-rich matrix, that is capable of binding and "presenting" growth factors. All of these functions could, and probably do, contribute to the observed increases in hematopoiesis in these cultures. In the absence of growth factors like GM-CSF, progenitor cells undergo apoptosis and die rapidly.36 FGF-4-induced increases in stromal cell number may result in greater concentrations of growth factors that either directly stimulate progenitor expansion or prevent progenitor cells from undergoing apoptosis.
Cultures of hematopoietic stromal cells can be used to detect and measure the frequency of early progenitor cells capable of multilineage differentiation. Limiting-dilution assays of so-called "long-term culture initiating cells" (LTC-IC) have come into wide use. Considerable optimism has developed that these assays are measuring a cell close to the primitive hematopoietic stem cell (PHSC), but they suffer from problems of reproducibility and nonlinearity. Much of the difficulty with the assay appears to be attributable to problems in preparing uniform stromal monolayers that retain the capacity to support hematopoietic cell development. Our results demonstrate that the use of FGF-4 can solve many of these difficulties and should make the LTC-IC assay far more useful. 
